ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.830
-0.130 (-6.63%)
Apr 7, 2026, 4:00 PM EDT - Market closed
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $240.84 million as of April 8, 2026. Its market cap has increased by 502.74% in one year.
Market Cap
240.84M
Enterprise Value
210.82M
1-Year Change
502.74%
Ranking
Category
Stock Price
$1.83
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $240.84M, a decrease of -77.20%. That is a compound annual growth rate of -22.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 257.95M | 321.03% |
| Dec 31, 2025 | 61.27M | -30.44% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coherus Oncology | 250.32M |
| Orchestra BioMed Holdings | 249.30M |
| Polaryx Therapeutics | 244.29M |
| Cellectis | 242.59M |
| Arcturus Therapeutics Holdings | 241.88M |
| Camp4 Therapeutics | 241.42M |
| Keros Therapeutics | 241.34M |
| Context Therapeutics | 240.72M |